Piper Sandler’s Defensive Biotech Selection Amid Market Uncertainty
Piper Sandler’s Defensive Biotech Selection Amid Market Uncertainty
ryasick As market volatility rattles investor confidence worldwide, Piper Sandler has unveiled a strategic lineup of eight defensive growth stocks within the biopharmaceutical sector. This announcement follows a turbulent period where equities experienced a 3% dip in the S&P 500 on Monday, catalyzed by a lackluster U.S. jobs report. Although the benchmark index displayed signs ...











